Courtney Andersen studies the role of estrogen receptor-alpha in ovarian cancer.
Chris Barnes investigates the structural details by which transcription factor activity regulates RNA Polymerase II during the universal process of eukaryotic gene expression.
Soma Jobaggy studies nitrated fatty acid pharmacology and the antioxidant response in hypertensive end-organ damage.
Allison Nagle studies growth factor receptor signaling in breast cancer.
Pallavi Bansal

Associate Director/Senior Project Manager, US Tasigna, Novartis Oncology, Greater New York Area, NY


Graduated: 2007
Induction of CD25B Following DNA Damage: Implications for Cell Cycle Resumption and Tumorgenesis

After graduation, in their own words:

After graduation I joined Cleveland clinic as a  morgenthaler research fellow. After two years decided that bench research was not that I enjoyed most so I decided to take a different path. I graduated from Wharton (univ of pennsylvania) with a MBA last year and joined Novartis Oncology in the commercial organization. 


11/27/2017 8:30 AM Molecular Pharmacology Journal Club
Lloyd Harvey

11/30/2017 12:00 PM Pharmacology & Chemical Biology Seminar Series
Jeffrey L. Brodsky, Ph.D.

12/4/2017 8:30 AM Molecular Pharmacology Journal Club
Andrew Lamade

Pharmacology and Chemical Biology Event Calendar

Program Achievements

Molecular Pharmacology Graduate Program Ranked #2 in National Research Council Rankings

Molecular Pharmacology Graduate Program Ranked #2 in Faculty Scholarly Productivity Index

Outcomes:  Time to disseration, last five graduating clasess:  4.5 years, Completion Rate: 84.8%

Ranked #12 in National of Institute of Health funding of departments of Pharmacology

Ranked in the top 15 in funding for twenty consecutive years

Back to Top